Navigation Links
New nanoparticle vaccine is more effective but less expensive
Date:9/17/2007

Good news for public health: Bioengineering researchers from the EPFL in Lausanne, Switzerland, have developed and patented a nanoparticle that can deliver vaccines more effectively, with fewer side effects, and at a fraction of the cost of current vaccine technologies.

Described in an article appearing online September 16 in the journal Nature Biotechnology, the vaccine delivery platform is a deceptively simple combination of nanotechnology and chemistry that represents a huge advantage over current vaccine methods. This technology may make it possible to vaccinate against diseases like hepatitis and malaria with a single injection. And at an estimated cost of only a dollar a dose, this technology represents a real breakthrough for vaccine efforts in the developing world.

A vaccination is an injection of a non-virulent form of a pathogen or molecule from a pathogen (known as an antigen), to which the immune system responds, destroying and then developing a memory for the pathogen. Later, when a virulent form of the pathogen comes along, this memory kicks in and the intruder is quickly eradicated. Most vaccines protect against viruses or bacteria, but vaccine techniques are also being explored as a way to kill cancer cells.

Thanks to recent advances, an immune response can be triggered with just a single protein from a virus or bacterium. Recent research has also shown that the best way to get sustained immunity is to deliver an antigen directly to specialized immune cells known as dendritic cells (DCs).

This technique is not yet used clinically because there are two difficulties to overcome in targeting the DCs: first, there are not very many of these cells in the skin or muscle, where injections are usually made, so obtaining an adequate immune response with a single injection is difficult; and second, activating the DCs requires co-delivering a danger signal of some sort, otherwise the immune system will just ignore it.
'/>"/>

Contact: Mary Parlange
mary.parlange@epfl.ch
41-216-916-113
Ecole Polytechnique Fd rale de Lausanne
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. DNA Molecules Used To Assemble Nanoparticles
2. Imaging Lymph Nodes with Nanoparticles
3. Taking Aim With Nanoparticle PEBBLEs
4. Probing The Promise And Perils Of Nanoparticles
5. Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications
6. Probing the promise and perils of nanoparticles
7. Nanoparticles offer new hope for detection and treatment
8. Nanoparticle Breast Cancer Drug Approved by FDA
9. Novel gene-silencing nanoparticles shown to inhibit Ewings sarcoma
10. Using nanoparticles, in vivo gene therapy activates brain stem cells
11. Nanoparticles, nanoshells, nanotubes: How tiny specks may provide powerful tools against cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...European countries has shown that closing schools ...ld have a significant role in reducing illness tra...journal BMC Infectious Diseases compared opportu...olidays, finding that they were reduced when schoo...rp University, Belgium, led a team of European res...
(Date:11/25/2009)... the stomach, may be used to boost resistance to, ...ale School of Medicine researchers report in a stu...Neuroscience . , Parkinson,s disease is caused b... the midbrain known as the substantia nigra, which...production of dopamine in late-stage Parkinson,s c...
(Date:11/25/2009)... the heart pumps some 250 million liters of blood ...cle fibers of the heart have to be extremely durab...bauer, vice chair of the Department of Medicine II...f. Dr. H. A. Katus), has discovered a protein that...muscular unit, the sarcomere. In cooperation with ...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Hormone ghrelin can boost resistance to Parkinson's disease 2New genetic cause of cardiac failure discovered 2Dallas County Jury Finds in Favor of Family in Medical Malpractice Suit 61260 1Dallas County Jury Finds in Favor of Family in Medical Malpractice Suit 61260 2GREENGUARD Launches Comprehensive Health Based Certification Pilot Program 61257 1GREENGUARD Launches Comprehensive Health Based Certification Pilot Program 61257 2First Citizens Bank to Offer mPay Gateways Point of Care Patient Payment System to Its Health Care Customers 61254 1First Citizens Bank to Offer mPay Gateways Point of Care Patient Payment System to Its Health Care Customers 61254 2
...NTO, ON Researchers are closer to understanding w...e way they look, behave, think, and fight off dise...tical. , Innovative research from the Universi...r Research has uncovered potential new explanation...n and heart tissue from humans and chimpanzees, U ...
...orld leaders prepare to discuss conservation-frien...ve threatens a new wave of deforestation in the So...sity of East Anglia and Brazils Goeldi Museum high...primary rain forest. , Working in the north-east...entists undertook the single-largest assessment of...
...anxiety and aggression that result from social iso...zyme that controls production of a brain hormone. ...niversity of Illinois at Chicago College of Medici...the Proceedings of the National Academy of Science...because social isolation in both animals and human...
Other Biology News:University of Toronto finds humans and chimps differ at level of gene splicing 2Single-largest biodiversity survey says primary rainforest is irreplaceable 2Effects of social isolation traced to brain hormone 2
(Date:11/26/2009)...tion of ultrasmall transistors and more powerful c...ducting nanowires are closer to reality after a ke...ty and the University of California at Los Angeles...anowires with layers of different materials that a... critical requirement for making efficient transis...
(Date:11/25/2009)...A RATON, Fla., Nov. 25 For many bu... BodyLogicMD. The nation,s largest and fastest gr...clusively in medically supervised bioidentical ho...its network since November 2008 - from 21 to 36...ician-owned centers, including one in Puerto Rico,...
(Date:11/25/2009)...re-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: ....D., president and chief executive officer, will p...e Conference. , ,Presentation details are as foll...ence,Date: Tuesday, December 1, 2009,Time: ...Palace Hotel, New York, NY,Webcast: <a href=,ht...
(Date:11/24/2009)...vestment bank KTA Capital,s client Neuren Pharmace...vertible note private placement with a U.S. instit...ed by KTA Capital as Neuren,s exclusive placement ...York (PRWEB) November 23, 2009 -- The independent ...TA Capital") has announced that its client Ne...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...nt Portfolio -, SAN DIEGO, Oct. 2 Orexigen(R) Th...cal company focused on the treatment,of obesity an...today,announced the initiation of its first clinic...lease formulation of zonisamide plus olanzapine.,T... examine the,effectiveness of OREX-003 in mitigati...
...,(Nasdaq: CLRT ), a premier anatomic pathology an...ists, oncologists and the pharmaceutical industry,...rews, is featured in an,exclusive interview on Wal...es viewers an overview of the company, and the,sig... To view the clip in its entirety, visit:, http:...
...otherapy in U.S. to be Indicated ... Cell Therapeutics, Inc. (CTI),(Nasdaq and MTA: C...emental,Biologics License Application (sBLA) with ...e of Zevalin(R) ([90Y]-ibritumomab tiuxetan) as,co...reviously untreated,patients with follicular non-H...
Other Biology Technology:Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain 2Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain 3Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain 4[video] Ronald Andrews, CEO of Clarient, Inc. Discusses Agreement With University of Pennsylvania School of Medicine on WallSt.net's 3-Minute Press Show 2Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 2Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 3Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 4Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 5
Amino Acid Mixture Minus Leucine from Promega
Zero Blunt TOPO PCR Cloning Kit for Sequencing with One Shot TOP10 Electrocomp E. coli from Invitrogen
Zero Blunt TOPO PCR Cloning Kit for Sequencing with One Shot TOP10 Electrocomp E. coli from Invitrogen
Cultrex BME with phenol red from Trevigen
Biology Products: